Boehringer Ingelheim releases breakthrough findings on COPD in new study published in the Lancet…
Tag:
Boehringer Ingelheim
-
-
Other
Boehringer Ingelheim’s EMPA-REG OUTCOME® long-term trial improves understanding of type 2 diabetes and cardiovascular diseases
Beirut, Lebanon – 3 July 2017- Boehringer Ingelheim, one of the world’s leading pharmaceutical…
-
Business
Boehringer Ingelheim Middle East and North Africa (MENA) achieved a sales growth of 16% in 2016
Net sales rise to some 15.9 billion euros (currency-adjusted: +7.3 per cent; in euro…
-
Boehringer Ingelheim Middle East and North Africa Region achieved a sales growth of 26%…
Older Posts